Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.
El Khoury P, Roussel R, Fumeron F, Abou-Khalil Y, Velho G, Mohammedi K, Jacob MP, Steg PG, Potier L, Ghaleb Y, Elbitar S, Ragot S, Andreata F, Caligiuri G, Hadjadj S, Boileau C, Marre M, Abifadel M, Varret M, Hansel B.
El Khoury P, et al. Among authors: ragot s.
Diabetes Obes Metab. 2018 Apr;20(4):943-953. doi: 10.1111/dom.13181. Epub 2018 Jan 14.
Diabetes Obes Metab. 2018.
PMID: 29205760
Clinical Trial.